AntriaBio Inc Stock OTC Bulletin Board
Equities
US0372301095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 22 | Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell | MT |
May. 22 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 23.49M | Capitalization | 143M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -49M | EV / Sales 2024 * | - |
Net cash position 2024 * | 86M | Net cash position 2025 * | 68M | EV / Sales 2025 * | 3.19 x |
P/E ratio 2024 * |
-3.04
x | P/E ratio 2025 * |
-4.54
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.62% |
Latest transcript on AntriaBio Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-07-25 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Daron Evans
DFI | Director of Finance/CFO | 50 | Jan. 23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 19-02-09 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 19-11-19 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |